myCOPD: Trooper Study

Randomised controlled study (RCT)

Online versus face-to-face pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: randomised controlled trial.

We set out to obtain evidence whether the online pulmonary rehabilitation (PR) programme ‘my-PR’ is non-inferior to a conventional face-to-face PR in improving physical performance and symptom scores in patients with COPD.

We carried out a two-arm parallel single-blind, randomised controlled trial, where the online arm carried out pulmonary rehabilitation in their own homes and the face to face arm in a local rehabilitation facility. The participants included 90 patients with a diagnosis of Chronic  Obstructive Pulmonary Disease (COPD), modified Medical Research Council score of 2 or greater referred for pulmonary rehabilitation (PR), randomised in a 2:1 ratio to online (n=64)  or face-to-face PR (n=26).

The adjusted mean difference for the 6 min walk test (6MWT) between groups for the intention-to-treat (ITT) population was 23.8 m with the lower 95% CI well above the non-inferiority threshold of −40.5 m at −4.5 m with an upper 95% CI of +52.2 m. This result was consistent in the per-protocol (PP) population with a mean adjusted difference of 15 m (−13.7 to 43.8). The CAT score difference in the ITT was −1.0 in favour of the online intervention with the upper 95% CI well below the non-inferiority threshold of 1.8 at 0.86 and the lower 95% CI of −2.9. The PP analysis was consistent with the ITT.

In summary, this meant the 6-week programme of online supported PR was non-inferior to the conventional model delivered in face to face sessions in terms of effects on 6MWT distance and symptom scores, and was safe and well-tolerated.

View “Online versus face-to-face pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: randomised controlled trial ” study at www.bmj.com

Download PDF (831kb)

More Case Studies

myCOPD: West Lothian

West Lothian Health Board in Scotland undertook a survey of patients who had been given myCOPD between Dec 2017 and July 2018.

read more

myCOPD: Rescue Study

A randomised controlled feasibility trial of an E-health platform supported care vs usual care after exacerbation of COPD.

read more

Contact us

We're happy to answer any of your questions, please send an email to the relevant team. We're available Monday to Friday from 8am to 5pm, except bank holidays and will reply as soon as possible, usually the same day.